Jincheng Pharmaceutical(300233.SZ): Net profit in 2025 down 77.55% year-on-year, plans to distribute 1.5 yuan for every 10 shares

NightAirdropper · 2026-03-29T04:44:56+00:00

Gelonghui, March 26 — Jincheng Pharmaceutical (300233.SZ) announced its 2025 annual report. During the reporting period, due to industry and policy factors such as market competition and national centralized procurement, some products in the intermediate and formulation segments experienced significant year-over-year declines in both price and sales volume. During the reporting period, the company achieved operating revenue of 2.737 billion yuan, a decrease of 18.87% year-over-year; net profit attributable to shareholders of the listed company was 44.1863 million yuan, a decrease of 77.55% year-over-year. A cash dividend of 1.5 yuan per 10 shares was distributed to all shareholders.

NightAirdropper

2026-03-29 04:44:56

Gelonghui March 26丨Jincheng Pharmaceutical (300233.SZ) announced its annual report for 2025. During the reporting period, the intermediate and formulation segments experienced a significant decline in product prices and sales year-on-year due to market competition and national procurement and other industry and policy factors. In the reporting period, the company achieved operating revenue of 2.737 billion yuan, a year-on-year decrease of 18.87%; the net profit attributable to shareholders of the listed company was 44.1863 million yuan, a year-on-year decrease of 77.55%. A cash dividend of 1.5 yuan per 10 shares will be distributed to all shareholders.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.